引用次数
引用: 116,318
H-指数: 150
I10-指数 : 474
出版物: 602
Incidence of gastric cancer and breast cancer in CDH1 (E-cadherin) mutation carriers from hereditary diffuse gastric cancer families.
Paul DP Pharoah , Parry Guilford , Carlos Caldas , International Gastric Cancer Linkage Consortium
Gastroenterology 121 ( 6) 1348 -1353
461
2001
The impact of prophylactic total gastrectomy on health-related quality of life: a prospective cohort study.
Elizabeth Worster , Xinxue Liu , Susan Richardson , Richard H Hardwick
Annals of Surgery 260 ( 1) 87 -93
26
2014
PERSEPHONE: 6 versus 12 months (m) of adjuvant trastuzumab in patients (pts) with HER2 positive (+) early breast cancer (EBC): Randomised phase 3 non-inferiority trial with definitive 4-year (yr) disease-free survival (DFS) results.
Helena Margaret Earl , Louise Hiller , Anne-Laure Vallier , Shrushma Loi
Journal of Clinical Oncology 36 506 -506
90
2018
Integrative cluster classification to predict pathological complete response to neoadjuvant chemotherapy in early breast cancer.
Emilio Alba , Oscar M Rueda , Ana Lluch , Joan Albanell
Journal of Clinical Oncology 36 579 -579
2
2018
Dynamic genomic instability modulation by neoadjuvant therapy in early breast cancer (GEICAM/2006-03_2006-14).
Emilio Alba , Oscar M Rueda , Ana Lluch , Joan Albanell
Journal of Clinical Oncology 36 592 -592
2018
Inclusion of KI67 significantly improves performance of the PREDICT prognostication and prediction model for early breast cancer.
Gordon C Wishart , Emad Rakha , Andrew Green , Ian Ellis
BMC Cancer 14 ( 1) 908 -908
29
2014
Lymphocyte Invasion in IC10/Basal-Like Breast Tumors Is Associated with Wild-Type TP53
David Quigley , Laxmi Silwal-Pandit , Ruth Dannenfelser , Anita Langerød
Molecular Cancer Research 13 ( 3) 493 -501
36
2015
Abstract A31: Integrative differential allelic expression analysis efficiently reveals the biology underlying risk to breast cancer
Joana Xavier , Roslin Russell , Bernardo P Almeida , Nordiana Rosli
Molecular Cancer Research 14
3
2016
Abstract B06: CDK7: A marker of poor prognosis and tractable therapeutic target in triple-negative breast cancer
Bo Li , Triona Ni Chonghaile , Yue Fan , Rut Klinger
Molecular Cancer Research 14
2016
Abstract PR01: Understanding the role of BCL11A in triple-negative breast cancer
Kyren Lazarus , Carlos Caldas , Pentao Liu , Walid T Khaled
Molecular Cancer Research 14
2016
Abstract A30: RATHER: High-resolution molecular profiling of invasive lobular breast cancers
Suet-Feung Chin , Magali Michault , Ian Majewski , Tesa M Severson
Molecular Cancer Research 14
2016
Abstract B020: A copy number and expression based classifier for breast cancer tumors
Oscar M Rueda , Raza H Ali , Christina Curtis , Suet-Feung Chin
Molecular Cancer Research 11
2013
Abstract B017: A targeted sequencing approach to characterize the mutational profiles of 178 genes in 2600 primary breast tumors
Bernard Pereira , Suet-Feung Chin , Oscar M Rueda , Michelle Osborne
Molecular Cancer Research 11
2013
The GATA3 X308_Splice breast cancer mutation is a hormone context-dependent oncogenic driver.
Natascha Hruschka , Mark Kalisz , Maria Subijana , Osvaldo Graña-Castro
Oncogene 39 ( 32) 5455 -5467
3
2020
Genomic imbalances and patterns of karyotypic variability in mantle-cell lymphoma cell lines.
Jordi Camps , Itziar Salaverria , Maria J Garcia , Esther Prat
Leukemia Research 30 ( 8) 923 -934
47
2006
Allele-Specific Up-Regulation of FGFR2 Increases Susceptibility to Breast Cancer
Kerstin B Meyer , Ana-Teresa Maia , Martin O'Reilly , Andrew E Teschendorff
PLoS Biology 6 ( 5) e108
328
2008
Molecular staging of cancer: is it time?
Carlos Caldas ,
The Lancet 350 ( 9073) 231
8
1997
Translation of the ER[alpha]-PR crosstalk story to the clinic (the PIONEER study), and further preclinical exploration of the diverse role of progestins in ER-positive breast cancer
Sanjeev S Kumar , Rasmus Siersbaek , Sankari Nagarajan , Elena Provenzano
Oncology Abstracts
2019
TOX3 Mutations in Breast Cancer
James Owain Jones , Suet-Feung Chin , Li-An Wong-Taylor , Donna Leaford
PLoS ONE 8 ( 9) e74102
21
2013
Evaluation of flap endonuclease-1 (FEN1) as a prognostic, predictive, and therapeutic target in breast (BC) and ovarian cancer (OVC).
Tarek MA Abdel-Fatah , Roslin Russell , David J Maloney , Vivek Mohan
Journal of Clinical Oncology 31 1016 -1016
2013